Healthcare Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine Updated : September 16, 2020 08:20 AM IST SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.